Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: | Lynley 150/30 ED |
Active Ingredients: | Ethinylestradiol 30mcg Levonorgestrel 150mcg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Max Health Limited |
Manufacturer: | Lupin Limited, Pithampur, India |
Dated this 5th day of March 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).